177Lu-DOTATATE for Recurrent Meningioma

Abroad (travel likely)RecruitingPHASE2

Conditions

Recurrent Meningioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck, Austria

  • Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken, Vienna, Austria

  • Centre Leon Berard, Lyon, France

  • CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer, Lyon, France

    Contact: Study coordinator (Dr François Ducray)
  • Assistance Publique - Hopitaux de Marseille APHM - Hopital de La Timone (APHM), Marseille, France

  • Centre Eugene Marquis, Rennes, France

    Contact: Study coordinator (Dr. Elodie Vauleon)
  • CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole, Toulouse, France

    Contact: Study coordinator (Dr Vija Lavinia)
  • CHRU de Nancy - Hopitaux De Brabois, Vandœuvre-lès-Nancy, France

  • Gustave Roussy, Villejuif, France

  • Universitaetsklinikum - Essen, Essen, Germany

    Contact: Study coordinator (Dr. Sied Kebir)
  • University Frankfurt - Goethe Univ. - University Hospital Frankfurt- Klinik für Neurologie Funktionsbereich Neuroonkologie, Frankfurt, Germany

    Contact: Study coordinator (Dr Michael Burger)
  • Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital, Heidelberg, Germany

    Contact: Study coordinator (Prof. Antje Wick)
  • Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern, München, Germany

    Contact: Study coordinator (Prof. Louisa von Baumgarten)
  • Oslo University Hospital - Radiumhospitalet, Oslo, Norway

    Contact: Study coordinator (Dr. Petter Brandal)
  • St Olavs University Hospital - St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway

    Contact: Study coordinator (Prof. Tora Solheim)
  • Vall D Hebron - Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia, Barcelona, Spain

    Contact: Study coordinator (Dr. Maria Vieito Villar)
  • Hospital Universitario 12 De Octubre, Madrid, Spain

    Contact: Study coordinator (Dr. Juan Manuel Sepulveda)
  • Oncology Institute of Southern Switzerland (IOSI) - Ospedale San Giovanni, Bellinzona, Switzerland

    Contact: Study coordinator (Prof. Gaetano Paone)
  • UniversitaetsSpital Zurich - Neurology Clinic, Zurich, Switzerland

    Contact: Study coordinator (Prof. Michael Weller)
Study leads
  • Prof. Nathalie Albert

    Principal Investigator

    EORTC Study Coordinator